Medtronic plc.'s $49.9 billion Covidien acquisition, which closed in January 2017, boosted the company's fiscal year 2016 revenue 42 percent (or 7 percent on a constant currency basis, which includes a first quarter extra week benefit) to a record $28.8333 billion. Fourth quarter revenue grew 4 percent (6 percent at constant currency) to $7.6 billion, beating analysts' expectations for 3 percent growth. Read More
